Related Experiment Videos
The pathobiology of acute asthma
1Division of Pulmonary and Critical Care Medicine, University Hospitals of Cleveland, Ohio, USA. erm2@po.cwru.edu
Clinics in Chest Medicine
|July 25, 2000
Summary
Acute bronchial asthma affects millions, causing significant economic and health burdens. This review explores the unknown causes of asthma exacerbations and proposes new treatments.
Area of Science:
- Pulmonology
- Clinical Medicine
- Epidemiology
Background:
- Acute bronchial asthma is a prevalent respiratory condition with substantial medical and economic consequences.
- Asthma exacerbations are linked to most morbidity and all mortality, driving healthcare costs.
- The underlying factors and pathobiology of acute asthma exacerbations are poorly understood.
Purpose of the Study:
- To examine the factors contributing to asthma destabilization.
- To explore the pathogenesis and pathobiology of acute asthma.
- To suggest effective treatments for acute asthma episodes.
Main Methods:
- Literature review of existing studies on asthma exacerbations.
- Analysis of epidemiological data on asthma prevalence and costs.
- Synthesis of current knowledge on asthma pathobiology.
Main Results:
- Asthma affects 12-14 million individuals in the US, costing over $6 billion annually.
- Treatment of acute exacerbations constitutes the majority of asthma-related healthcare expenditures.
- Key factors destabilizing asthma and its pathobiology remain largely uninvestigated.
Conclusions:
- Further research into the causes of asthma exacerbations is crucial.
- Understanding asthma pathobiology can lead to improved treatment strategies.
- Effective management of acute asthma requires addressing its underlying destabilizing factors.